Next Article in Journal
Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women
Next Article in Special Issue
Single-Shot ChAd3-MARV Vaccine in Modified Formulation Buffer Shows 100% Protection of NHPs
Previous Article in Journal
Barriers and Facilitators of Romanian HPV (Human Papillomavirus) Vaccination
Previous Article in Special Issue
Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials
 
 
Article

Article Versions Notes

Vaccines 2022, 10(10), 1723; https://doi.org/10.3390/vaccines10101723
Action Date Notes Link
article pdf uploaded. 15 October 2022 12:34 CEST Version of Record https://www.mdpi.com/2076-393X/10/10/1723/pdf-vor
article xml file uploaded 26 October 2022 05:32 CEST Original file -
article xml uploaded. 26 October 2022 05:32 CEST Update https://www.mdpi.com/2076-393X/10/10/1723/xml
article pdf uploaded. 26 October 2022 05:32 CEST Updated version of record https://www.mdpi.com/2076-393X/10/10/1723/pdf
article html file updated 26 October 2022 05:34 CEST Original file -
article html file updated 26 October 2022 05:35 CEST Update -
article html file updated 28 February 2023 18:17 CET Update -
article html file updated 1 March 2023 21:57 CET Update https://www.mdpi.com/2076-393X/10/10/1723/html
Back to TopTop